26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

314<br />

Chapter | 10 Hemostasis<br />

concentrations <strong>of</strong> serotonin, ADP, or collagen; platelet<br />

ATP, ADP, and serotonin content was decreased; and secretion<br />

<strong>of</strong> Ca 2 and Mg 2 by activated platelets was markedly<br />

decreased ( Meyers et al ., 1981 ). More recent studies have<br />

demonstrated that, in addition to the dense granule deficiency,<br />

the collagen-induced increase in cytosolic Ca 2 ,<br />

through the PLC γ pathway (see Sections II.B.3.a and c), is<br />

depressed in the platelets <strong>of</strong> Japanese black cattle affected<br />

with CHS ( Shiraishi et al ., 2002a, 2002b ). These results suggest<br />

an additional mechanism for the decreased platelet function<br />

in CHS. A dense granule storage defect, similar to that<br />

in CHS, has been described in three families <strong>of</strong> American<br />

cocker spaniel dogs with moderate to severe bleeding<br />

(Callan et al ., 1995 ). Although these dogs had a decrease in<br />

ADP content and an increased ATP:ADP ratio, in contrast<br />

to CHS, the number and morphology <strong>of</strong> dense granules<br />

on ultrastructural studies and concentrations <strong>of</strong> serotonin<br />

appeared normal ( Callan et al ., 1995 ). The defect identified<br />

in these dogs appears to be an isolated abnormality in the<br />

δ -granule adenine nucleotide storage ( Callan et al ., 1995 ).<br />

Platelet dysfunction in basset hounds has been attributed<br />

to defective intracellular signaling. Ultrastructural appearance,<br />

surface molecules, and granule constituents appear<br />

normal in these dogs; however, secretion <strong>of</strong> dense granules,<br />

expression <strong>of</strong> fibrinogen binding sites on GPIIb-IIIa,<br />

and platelet aggregation are impaired in response to several<br />

platelet agonists ( Catalfamo et al ., 1986 ). An elevation<br />

<strong>of</strong> basal cAMP levels has been detected in these platelets<br />

and is thought to result from a defect in cAMP metabolism<br />

(Boudreaux et al ., 1986 ; Catalfamo and Dodds, 2000 ). As<br />

previously mentioned, elevated cAMP levels reduce platelet<br />

reactivity through a number <strong>of</strong> mechanisms (see Section<br />

II.B.3.d, and Table 10-3) and thus would be detrimental during<br />

hemostatic challenge. The thrombopathia <strong>of</strong> Simmental<br />

cattle has also been attributed to defective intracellular signal<br />

pathways. Whole blood from these cattle exhibit normal<br />

clot retraction, but aggregation in response to ADP and collagen<br />

is markedly impaired ( Searcy et al ., 1990 ). Similar to<br />

basset hounds, these cattle express normal levels <strong>of</strong> GPIIb-<br />

IIIa on the platelet surface; however, in contrast, dense<br />

granule secretion is unimpaired ( Searcy et al ., 1990 ). The<br />

cytoskeletal assembly in response to ADP was shown to be<br />

incomplete, and this is thought to result in delayed activation<br />

<strong>of</strong> GPIIb-IIIa and therefore delayed fibrinogen binding<br />

(Frojmovic et al ., 1996 ; Searcy et al ., 1994 ).<br />

4. Coagulation Factor Disorders<br />

a. Fibrinogen Deficiency<br />

As previously discussed, fibrinogen not only takes part in<br />

primary hemostasis but is imperative for final clot formation<br />

in secondary hemostasis (see Section II.C.4). Fibrinogen is<br />

primarily synthesized in hepatocytes through production<br />

and assembly <strong>of</strong> three polypeptide chains (A α , Bβ , and γ ),<br />

which subsequently dimerize to form hexameric fibrinogen<br />

(Asselta et al ., 2006 ). Each <strong>of</strong> the fibrinogen chains is<br />

encoded by separate genes, and all are required for successful<br />

assembly and secretion ( Roy et al ., 1991 ). Numerous<br />

genetic defects have been identified in humans, with variable<br />

influence on production, secretion, and function <strong>of</strong> the<br />

molecule. Hereditary fibrinogen deficiencies are generally<br />

categorized into quantitative (afibrinogenemia and hyp<strong>of</strong>ibrinogenemia)<br />

and qualitative disorders (dysfibrinogenemia)<br />

(Asselta et al ., 2006 ). In humans, the quantitative deficiencies<br />

are generally inherited as autosomal recessive disorders,<br />

whereas the qualitative deficiencies are generally autosomal<br />

dominant ( Asselta et al ., 2006 ). Bleeding tendencies are variable;<br />

however, umbilical cord bleeding, hemorrhages from<br />

mucosal surfaces, hemarthroses, and hematomas are some<br />

<strong>of</strong> the more frequently encountered symptoms ( Lak et al .,<br />

1999 ). Hemarthrosis and hematomas tend to be less frequent<br />

and severe than in the hemophilias ( Lak et al ., 1999 ). In afibrinogenemic<br />

and hyp<strong>of</strong>ibrinogenemic patients, the majority<br />

<strong>of</strong> bleeding episodes occurs as a result <strong>of</strong> trauma or surgery<br />

(71% and 80%, respectively), with the remainder comprising<br />

spontaneous episodes ( Acharya et al ., 2004 ). Thrombin time<br />

is prolonged in fibrinogen defects; however, partial thromboplastin<br />

time and prothrombin time are also prolonged<br />

because <strong>of</strong> their dependency on a fibrin clot end point (see<br />

Section III.B.3.d). Further investigation should include quantification<br />

<strong>of</strong> fibrinogen, an absence indicating afibrinogenemia,<br />

and decreased levels in hyp<strong>of</strong>ibrinogenemia. Although<br />

fibrinogen concentration is generally within reference intervals<br />

for dysfibrinogenemias, some present with low fibrinogen<br />

concentrations ( Hayes, 2002 ). It is important to measure<br />

activity in conjunction with concentration in order to reveal<br />

functional deficiencies. Typically a 1:1 ratio <strong>of</strong> functional to<br />

quantitative levels are present; however, in dysfibrinogenemia<br />

the ratio is more typically 1:2, with disproportionately<br />

low function compared to concentration ( Hayes, 2002 ).<br />

Although significant progress has been made in the<br />

characterization <strong>of</strong> human fibrinogen deficiencies, this disorder<br />

is still exceedingly rare and poorly characterized in<br />

animals. Fibrinogen defects have historically been identified<br />

in goats and various breeds <strong>of</strong> dog ( Dodds, 2000 ).<br />

More recent reports include a Border Leicester lamb with<br />

disproportionately low fibrinogen function when compared<br />

to concentration ( Fecteau et al ., 1997 ). However,<br />

in this report, diagnostic limitations prevented definitive<br />

distinction between dysfibrinogenemia and afibrinogenemia.<br />

<strong>Clinical</strong> signs were consistent with those reported<br />

in humans, including umbilical bleeding and a hematoma.<br />

A case <strong>of</strong> congenital afibrinogenemia was confirmed,<br />

through extensive testing, in a Bichon Frise. This patient<br />

experienced excessive bleeding at sites <strong>of</strong> venipuncture, a<br />

hematoma, and uncontrolled hemorrhage following ovariohysterectomy<br />

( Wilkerson et al ., 2005 ).<br />

Acquired deficiencies <strong>of</strong> fibrinogen are generally associated<br />

with consumptive coagulopathies, but they can also<br />

result from decreased production in liver failure.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!